Promising nonopioid approach for reducing neuropathic pain disrupts a protein interaction

Understanding and treating chronic neuropathic symptom has remained challenging owed to its analyzable nature. New probe from the laboratory of Clifford Woolf, MB, BCh, Ph.D., astatine Boston Children's Hospital's FM Kirby Neurobiology Center describes a caller attack for reducing symptom by disrupting interactions wrong pain-sensing nervus cells called nociceptors.